🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Title: Good Day BIO Live from San Diego – Tuesday, June 14, 2022 x.com/i/broadcasts/1…

#DEI is "not just about what happens in a company," says Eric Dube of Travere Therapeutics--watch as he explains #BIO2022

Panelists will share insights to maximize global partnerships and alliances to reduce clinical, regulatory, manufacturing, and distribution challenges for the next global pandemic. Sponsored by Novavax. #BIO2022 #SuperSession nuvi.me/dz7eks

Join today's discussion to learn more about the Accelerated Approval pathway and the impact these therapies have had on patients’ lives. #BIO2022 nuvi.me/8m4n1b

Happening at #BIO2022: James A. Geraghty joined Paul Hastings of Nkarta, Inc. to discuss Geraghty’s new book, which explores the origin of the Orphan Drug Act and the impact nearly 40 years later. nuvi.me/8327rb

As the world’s largest advocacy association representing member companies, we make the impossible, possible. Learn more about us at nuvi.me/iqvjzr

BIO President and CEO @DrMichelleBIO was recently awarded the BioGENEius Innovators Woman of the Year. nuvi.me/9th6vm

Top officials share a key COVID lesson at #BIO2022: Governments must support biotech. nuvi.me/ggg2f6

Good Day BIO Live from San Diego – Wednesday, June 15, 2022 x.com/i/broadcasts/1…

Today's Good Day BIO Live looks at what happened at yesterday with a look on what to expect today. Watch at the link below. nuvi.me/9mil1c

"I hope we're sitting here ten years from now saying clinical trials are an antiquated way of capturing clinical data." CEO of Biotechnology Innovation Organization, @DrMichelleBIO, shares her outlook on clinical trials in the latest episode of Breakthrough Economy. Learn more: nasdaq.com/breakthrough-e…

Reporting live from the #AcceleratedApproval panel at BIO Convention - this proven pathway is “overwhelmingly”used for orphan conditions making it incredibly meaningful for developing treatments for #rarediseases #BIO2022 #OneRareVoice

Hear from a panel of industry leaders, investors, and government representatives about the challenges in innovation for AMR. #BIO2022 nuvi.me/bjjo19

Hear an in-depth discussion on the importance of the Prescription Drug User Fee Act (PDUFA) VII and potential new policies needed to provide a pathway for innovative new treatment. Sponsored by Travere Therapeutics. #BIO2022 #SuperSession nuvi.me/1p33bc

Today's Good Day BIO Live looks at what happened at #BIO2022 yesterday with a look on what to expect today. Watch at the link below. nuvi.me/aiqwvd

Today's Good Day BIO Live! features exclusive interviews with BIO leadership and policy experts on AMR, Accelerated Approval, and the patient experience—plus a few clips of Venus Williams and a mother with a powerful patient story. Watch now. youtube.com/watch?v=mk1jTs…

Venus Williams shared how her diagnosis of Sjogren's syndrome is like a “box of chocolates.” Hear more of her interview with Erin Andrews on today’s Good Day BIO Live: nuvi.me/f7b8qj

We've enjoyed bringing the biotech community together again to celebrate their life saving work that allowed us to gather in person. Thanks to all who attended #BIO2022!

Paul Hastings, President & CEO of Nkarta Therapeutics, Nkarta, Inc., shares his approach for an equitable workforce on today’s Good Day BIO Live: nuvi.me/6r8cux

See a clip from yesterday's Fireside Chat with the Commissioner of Food and Drugs, Dr. Robert M. Califf. U.S. FDA #BIO2022